SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Logi who wrote (219)5/29/1997 12:03:00 PM
From: luis a. garcia   of 1115
 
Logi
Two years ago the stock run up was due to LIDAKOL passing the European
trials when tested against Zovirak then the expectation of passing the
phaseIII in the US. Trouble was they used an active placebo that is they used LIDAKOL vs LIDAKOL(ative) (Why the placebo was LIDAKOL inactive and not a dang sugar pill...is because FDA guidelines requires the placebo to be identical to the drug in every respect) and the test did not show statistical improvement over itself... it was a classic goof. This time it will not be repeated. So LIDAKOL is expected to pass phase III. PMA may take six months in this case or
less. FDA has been very proactive recently due to criticism in the past from patients awaiting treatment.
good luck
luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext